date:Nov 08, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it intends to repurchase 2,500,000 ordinary shares, starting on6 November2013, in order to cover its commitments under existing management and personnel option plans. Based on the closing price of the DSM share on NYSE Euronext on 5 November 2013 this would be equivalent to approximately 140 million.
This share repurchase program is anticipated to continue into Q1 2014 and is the first part of a program to